Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study

被引:0
|
作者
Silberstein, Stephen D. [1 ]
Ashina, Messoud [2 ]
Cohen, Joshua M. [3 ]
Seminerio, Michael J. [3 ]
Yang, Ronghua [3 ]
Ning, Xiaoping [3 ]
Ortega, Mario [3 ]
机构
[1] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Teva Pharmaceut, Frazer, PA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S194
引用
收藏
页码:S76 / S76
页数:1
相关论文
共 50 条
  • [41] Time Gained With Long-term Fremanezumab Treatment in Patients With Chronic and Episodic Migraine
    Marmura, M.
    Cohen, J. M.
    Ning, X.
    Campos, V. Ramirez
    Barash, S.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 117 - 117
  • [42] Long-Term Impact of Fremanezumab on Response Rates: Results of a 1-Year Study
    Newman, L. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 103 - 104
  • [43] Long-Term Impact of Fremanezumab on Response Rates: Results of a 1-Year Study
    Newman, Lawrence
    Cohen, Joshua
    Yeung, Paul
    Yang, Ronghua
    Ning, Xiaoping
    NEUROLOGY, 2019, 92 (15)
  • [44] Long-Term Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Migraine Patients with Concomitant Preventive Medication Use: Results of a 1-Year Study
    Lipton, R. B.
    Buse, D. C.
    Gandhi, S. K.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 107 - 108
  • [45] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Chronic Migraine: Interim Results of a One-Year Study
    McAllister, P.
    Yeung, P. P.
    Cohen, J. M.
    Gandhi, S. K.
    Fitzgerald, T.
    Yang, R.
    Ma, Y.
    Aycardi, E.
    HEADACHE, 2018, 58 : 86 - 87
  • [46] Onabotulinumtoxin A for Chronic Migraine with Medication Overuse: clinical results of a long-term treatment
    Grazzi, Licia
    Andrasik, Frank
    D'Amico, Domenico
    Leonardi, Matilde
    Raggi, Alberto
    Sansone, Emanuela
    CEPHALALGIA, 2017, 37 : 90 - 91
  • [47] Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment
    Licia Grazzi
    Neurological Sciences, 2017, 38 : 141 - 143
  • [48] Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment
    Grazzi, Licia
    NEUROLOGICAL SCIENCES, 2017, 38 : S141 - S143
  • [49] Pooled analysis of efficacy of fremanezumab for reducing disability and acute medication overuse in migraine patients
    Ashina, S.
    Cohen, J.
    Ning, X.
    Ramirez-Campos, V.
    Seminerio, M.
    Janka, L.
    Silberstein, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 156 - 156
  • [50] Acute treatment of episodic and chronic cluster headache with subcutaneous sumatriptan. Results of a 1-year long-term study
    Gobel, H
    Lindner, V
    Pfaffenrath, V
    Ribbat, M
    Heinze, A
    Stolze, H
    NERVENARZT, 1998, 69 (04): : 320 - 329